Medtronic Share-Based Payment Arrangement, Expense, after Tax decreased by 49.7% to $77.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $81.00M to $77.00M.
other_allocated_share_based_compensation_expense_net_of_tax| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.00M | $114.00M | $65.00M | $51.00M | $111.00M | $67.00M | $62.00M | $121.00M | $70.00M | $70.00M | $134.00M | $81.00M | $71.00M | $153.00M | $77.00M |
| QoQ Change | — | +96.6% | -43.0% | -21.5% | +117.6% | -39.6% | -7.5% | +95.2% | -42.1% | +0.0% | +91.4% | -39.6% | -12.3% | +115.5% | -49.7% |
| YoY Change | — | — | — | -12.1% | -2.6% | +3.1% | +21.6% | +9.0% | +4.5% | +12.9% | +10.7% | +15.7% | +1.4% | +14.2% | -4.9% |